Nasdaq:US$16.90 (-0.82) | HKEX:HK$27.20 (-0.95) | AIM:£2.52 (-0.11)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 3 Oct 2013

Analyst briefing on Chi-Med’s pharmaceutical R&D business on 9 October 2013